Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Antiviral Res. 2014 Mar 12;106:1–4. doi: 10.1016/j.antiviral.2014.03.001

Table 1.

Pre-steady-state rate constants for incorporation of EFdA-TP or dATP by RT and pol γ.a

Enzyme Nucleotide or analog kpol (s−1) Kd (μM) Efficiencyb (μM−1 s−1) Discriminationc
RT dATP 8.0 ± 0.7 3.8 ± 0.8 2.1 0.47
EFdA-TP 5.8 ± 0.3 1.3 ± 0.2 4.5
pol γd dATP 220 ± 16 3.2 ± 0.7 69 4,300
EFdA-TP 0.29 ± 0.02 18 ± 4 0.016
a

Kinetic parameters determined from at least eight (RT), or at least seven (pol γ) single turnover experiments with varying dATP or EFdA-TP concentrations.

b

Efficiency = kpol/Kd

c

Discrimination=efficiencydATPefficiencyEFdA